Answers are grounded in this paper and cite their sources.
Commentary shares the journey of a theranostician in molecular imaging and nuclear medicine, highlighting advances.
Having recently spoken about the legacy that we owe to the pioneers in the field at a meeting organised by the European Society of Molecular Imaging, I was initially perplexed when the Editor-in-Chief of this journal invited me to write about my own personal experiences in the field. However, the more that I thought about it, the more I appreciated the unique perspective that I have gained on molecular imaging and therapeutic nuclear medicine by having lived through a period of unprecedented advances in precision medicine. As an amateur historian, the history of nuclear medicine has always fascinated me and as I enter my anecdotage, I also felt it was an opportunity for me to reminisce about my own metamorphosis into a “theranostician”.
No takes yet. Share an insight, caveat, or question.
Rodney J. Hicks (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: